Group 1 - The core point of the news is that Hualu Bio has seen a stock price increase of 5.08%, reaching 22.75 CNY per share, with a trading volume of 190 million CNY and a turnover rate of 9.17%, resulting in a total market capitalization of 2.789 billion CNY [1] - Hualu Bio, established on June 8, 2010, and listed on April 12, 2021, specializes in the research, industrial cultivation, and sales of edible mushrooms, with revenue composition of 70.73% from enoki mushrooms and 29.27% from king oyster mushrooms [1] Group 2 - Among the top ten circulating shareholders of Hualu Bio, the Noan Multi-Strategy Mixed A Fund (320016) has recently entered the list, holding 1.0993 million shares, which accounts for 1.17% of the circulating shares, with an estimated floating profit of approximately 1.2092 million CNY [2] - The Noan Multi-Strategy Mixed A Fund was established on August 9, 2011, with a current scale of 1.855 billion CNY, achieving a year-to-date return of 5.21%, ranking 2743 out of 8838 in its category, and an annual return of 88.18%, ranking 316 out of 8089 [2] Group 3 - The fund manager of Noan Multi-Strategy Mixed A is Kong Xianzheng, who has been in the position for 5 years and 50 days, managing a total fund asset size of 5.608 billion CNY, with the best fund return during his tenure being 93.39% and the worst being -16.74% [3]
华绿生物股价涨5.08%，诺安基金旗下1只基金位居十大流通股东，持有109.93万股浮盈赚取120.92万元